Business Description
Beijing Science Sun Pharmaceutical Co Ltd
ISIN : CNE100002110
Share Class Description:
SZSE:300485: Class ACompare
Compare
Traded in other countries / regions
300485.China IPO Date
2015-06-26Description
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 14.72 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.5 | |||||
| 3-Year EBITDA Growth Rate | -67 | |||||
| 3-Year Book Growth Rate | 7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.43 | |||||
| 9-Day RSI | 34.95 | |||||
| 14-Day RSI | 36.99 | |||||
| 6-1 Month Momentum % | -20.65 | |||||
| 12-1 Month Momentum % | -20.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 26.3 | |||||
| Quick Ratio | 24.22 | |||||
| Cash Ratio | 22.81 | |||||
| Days Inventory | 259.65 | |||||
| Days Sales Outstanding | 48.3 | |||||
| Days Payable | 41.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.17 | |||||
| Dividend Payout Ratio | 0.84 | |||||
| 3-Year Dividend Growth Rate | 11.5 | |||||
| Forward Dividend Yield % | 1.17 | |||||
| 5-Year Yield-on-Cost % | 1.06 | |||||
| Shareholder Yield % | 1.23 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.43 | |||||
| Operating Margin % | -8.61 | |||||
| Net Margin % | 21.6 | |||||
| FCF Margin % | -6.65 | |||||
| ROE % | 2.97 | |||||
| ROA % | 2.82 | |||||
| ROIC % | -1.31 | |||||
| ROC (Joel Greenblatt) % | -6.05 | |||||
| ROCE % | -1.14 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.95 | |||||
| PE Ratio without NRI | 71.96 | |||||
| Shiller PE Ratio | 13.59 | |||||
| Price-to-Owner-Earnings | 116.99 | |||||
| PS Ratio | 7.67 | |||||
| PB Ratio | 1.03 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| Price-to-Operating-Cash-Flow | 159.73 | |||||
| EV-to-EBIT | -58.26 | |||||
| EV-to-EBITDA | -58.26 | |||||
| EV-to-Revenue | 5.02 | |||||
| EV-to-FCF | -76.93 | |||||
| Price-to-Projected-FCF | 1.19 | |||||
| Price-to-Graham-Number | 1.89 | |||||
| Price-to-Net-Current-Asset-Value | 3.03 | |||||
| Price-to-Net-Cash | 3.58 | |||||
| Earnings Yield (Greenblatt) % | -1.72 | |||||
| FCF Yield % | -0.9 | |||||
| Forward Rate of Return (Yacktman) % | -31.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Science Sun Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 476.57 | ||
| EPS (TTM) (Â¥) | 0.21 | ||
| Beta | 0.67 | ||
| Volatility % | 26.13 | ||
| 14-Day RSI | 36.99 | ||
| 14-Day ATR (Â¥) | 0.334501 | ||
| 20-Day SMA (Â¥) | 8.0945 | ||
| 12-1 Month Momentum % | -20.5 | ||
| 52-Week Range (Â¥) | 6.53 - 12.27 | ||
| Shares Outstanding (Mil) | 481.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Science Sun Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Science Sun Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Science Sun Pharmaceutical Co Ltd Frequently Asked Questions
What is Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485)'s stock price today?
The current price of SZSE:300485 is ¥7.34. The 52 week high of SZSE:300485 is ¥12.27 and 52 week low is ¥6.53.
When is next earnings date of Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485)?
The next earnings date of Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485) is .
Does Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485) is 1.17% (As of Today), Highest Dividend Payout Ratio of Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485) was 168. The lowest was 0.18. And the median was 0.27. The  Forward Dividend Yield % of Beijing Science Sun Pharmaceutical Co Ltd(SZSE:300485) is 1.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers